Zur Rose consolidates its position in Germany
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Zur Rose through its DocMorris subsidiary has acquired German rival Apo-rot, in a move that will further bolster its position in the country’s online pharmacy market.
You may also be interested in...
Bricks-And-Mortar Pharmacy In The Crosshairs As Zur Rose Aims To Become The Amazon Of European Healthcare
Swiss supply chain disruptor Zur Rose wants to break up the ancient monopoly of European bricks-and-mortar pharmacy and replace it with a tech-driven healthcare offering to rival that of retail giant Amazon, according to a member of the firm’s board, Olaf Heinrich.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.